The emerging clinical domain concerns composite sequences. Such synthetic entities merge portions from various peptide origins, allowing the development of novel therapeutic properties. This approach offers the https://chimerapeptides762846.anchor-blog.com/23600297/chimera-peptides-a-novel-therapeutic-frontier